The relationship between the appendix and Parkinson’s disease Posted on November 5, 2018April 3, 2019 by Nancy Braun The relationship between the appendix and Parkinson’s disease Read More
Important New Study Underway: Get Involved Posted on October 23, 2018October 23, 2018 by Nancy Braun About the “Economic Burden” Study The study seeks to capture more of the financial costs associated with Parkinson’s. Read More
INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS® – Parkinson’s Disease Updates Posted on October 9, 2018April 2, 2019 by Nancy Braun INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS® – Parkinson’s Disease Updates The International Congress of Parkinson’s Disease and Movement Disorders is taking place this week (Oct 5-9) in Hong Kong. This is an annual meeting of Movement Disorders scientists and physicians from around the world. Read More
APDA-funded Brigham and Women’s Hospital explores the genetic variants associated with Parkinson’s disease and other conditions Posted on September 27, 2018September 27, 2018 by Nancy Braun APDA-funded Brigham and Women’s Hospital explores the genetic variants associated with Parkinson’s disease and other neuropsychiatric conditions In classic biochemistry, ribonucleic acid (RNA) was thought to be a simple middle man between our genome and our proteins. Recently, however, it has become clear that RNA exists in multiple forms and plays a myriad of roles, including regulating protein production, regulating genome activity, and sensing environment. In fact, only a very small portion of DNA gets transcribed into RNA that creates protein. A much large portion gets transcribed into RNA that has various other functions. Read More
FDA New Analysis on PD Psychosis Treatment Posted on September 25, 2018September 27, 2018 by Nancy Braun FDA New Analysis on PD Psychosis Treatment On September 20, 2018, the FDA recently released results of a new analysis finding no new or unexpected safety risks associated with Nuplazid. The new analysis was initiated because of concerns raised in the media last spring, and reassures patients that they should continue to take Nuplazid as prescribed by their physician. The FDA report highlights a number of important concepts Read More
APDA Center for Advanced Research at University of Alabama School of Medicine Receives Udall Center Designation Posted on September 21, 2018December 17, 2018 by Nancy Braun APDA Center for Advanced Research at University of Alabama School of Medicine Receives Udall Center Designation Read More
APDA funded research suggests new approach to understanding the basic biology of PD Posted on August 13, 2018August 15, 2018 by Phil Franchina APDA funded research suggests new approach to understanding the basic biology of PD APDA-funded research conducted by Dr. Talene Yacoubian of the University of Alabama School of Medicine at Birmingham – one of APDA’s Centers for Advanced Research – suggests a new approach to understanding the basic biology of Parkinson’s disease. Read More
Dr. Rebecca Gilbert on Wisconsin Public Radio Posted on August 7, 2018September 27, 2018 by Nancy Braun Let’s Talk About Parkinson’s Disease with Dr. Rebecca Gilbert On Monday, August 6, 2018 Dr. Rebecca Gilbert joined the the Wisconsin Public Radio’s The Morning Show where she helps make complex things about PD simple to understand.. Read More
Dr. Gilbert Comments in Scientific American Magazine Posted on August 6, 2018August 6, 2018 by Nancy Braun Dr. Gilbert comments on Scientific American Magazine APDA’s Chief Scientific Officer Dr. Rebecca Gilbert spoke to Scientific American magazine about recent research on LRKK2 and what it could mean for both people with LRKK2 mutation and, importantly, for those who do not carry the mutation. Read More
Promising results from APDA-funded LRRK2 research Posted on August 2, 2018 by Nancy Braun Promising results from APDA-funded LRRK2 research On July 25, 2018, the APDA Center for Advanced Research at the University of Pittsburgh, led by the Center’s Director (and APDA Scientific Advisory Board member), Dr. J. Timothy Greenamyre, published results of a study highlighting the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease. Read More
